30 studies found for:    "Jervell and Lange-Nielsen syndrome" OR "Long QT Syndrome"
Show Display Options
Rank Status Study
21 Recruiting Pharmacokinetics of GS-6615 in Adults With Normal and Impaired Hepatic Function
Condition: Long QT Syndrome
Intervention: Drug: GS-6615
22 Not yet recruiting Worm Study: Modifier Genes in Sudden Cardiac Death
Conditions: Brugada Syndrome;   Long QT Syndrome 3
Interventions: Procedure: Dermal biopsy;   Drug: Ajmaline challenge;   Genetic: Whole-exome sequencing
23 Completed Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Condition: Prolonged QT Interval in EKG and Sudden Death
Interventions: Drug: Progesterone;   Drug: Placebo
24 Completed Characteristics of Andersen-Tawil Syndrome
Conditions: Andersen-Tawil Syndrome;   Andersen Syndrome
Intervention:
25 Terminated Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome
Condition: Andersen-Tawil Syndrome
Interventions: Dietary Supplement: Potassium;   Drug: Acetazolamide
26 Terminated Infant Medical Records: Case Report Proposal
Condition: Congenital Disorders
Intervention:
27 Recruiting Effect of GS-6615 on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT-3 Syndrome
Condition: Long QT-3 Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo to match GS-6615
28 Completed Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation
Condition: Healthy Volunteers
Intervention: Drug: Sotalol 80 mg
29 Completed The Effect of General Anesthesia on the Risk for Arrhythmia
Condition: Arrhythmia
Intervention:
30 Not yet recruiting Effect of GS-6615 on QT, Safety, and Tolerability in Adults With Long QT2 Syndrome
Condition: LQT2 Syndrome
Interventions: Drug: GS-6615;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years